The significant progressive decrease in adiponectin (Table 1) in line with increasing degree of insulin resistance (Table 1 and Figure 1) with increasing degrees of obesity indicate the utility of adiponectin as a screening tool. This evidence concerns the gene ADIPOQ and obesity due to melanocortin 4 receptor deficiency.